About Samuel Myllykangas
Samuel Myllykangas is CEO & Co-founder, director at SwitchPoint Bio Holding.
Experience
This experience comes from Samuel Myllykangas's profile and from SEC filings. For roles taken from filings, the years are when the filings name Samuel Myllykangas in the role, so the role may have started earlier or lasted longer.
SwitchPoint Bio Holding, Inc. Current
CEO & Co-founder, director
2026 – Present · Wilmington, DE
Analyzes blood cell biology for drug developers and clinical researchers.
QD
Quest Diagnostics
Vice President
2021 – 2025
BG
Blueprint Genetics
Managing Director
2011 – 2025
UH
University of Helsinki
Adjunct Professor
2001 – 2020
SU
Stanford University
Postdoctoral fellow
2009 – 2011
BD
Biohit Diagnostics
Researcher
1998 – 2001
Key Colleagues at Startups
The people Samuel Myllykangas works with at each company, as listed on that company's latest Form D.
SwitchPoint Bio Holding, Inc. · Form D, Mar 10, 2026
JP
Jussi Paananen
CTO & Co-founder, director
DP
David Proctor
Director